Because abnormal T cell activation is an important pathological feature of SLE, we further measured IFN-γ, IL-4, IL-17 and Foxp3 in T cells from SLE patients and from healthy controls. This evidence concerns the gene FOXP3 and systemic lupus erythematosus.